CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Candel Therapeutics Grants Options on 107,600 Shares to Four New Employees

By Public Technologies
  • Candel Therapeutics granted four new employees stock options to purchase 107,600 shares on Oct. 31, 2026.
  • The options carry an exercise price of $8.33 per share under the 2025 Inducement Plan.
  • Vesting covers 25% of the underlying shares on the first anniversary of each employee’s start date.
  • The remaining 75% vests in 36 equal monthly installments thereafter. All vesting requires continued service through the applicable vesting date.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Candel Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611021605PRIMZONEFULLFEED9868140) on November 02, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk